- Home
- Diabetology
- Proactive Aflibercept Therapy in Severe NPDR: Insights from the PANORAMA Trial

3w3 min read
Medical Article
Introduction Diabetic retinopathy (DR) is a leading cause of vision loss worldwide, progressing from nonproliferative diabetic retinopathy (NPDR) to proliferative diabetic retinopathy (PDR) and/or diabetic macular edema (DME). Severe NPDR carries a high risk of vision-threatening complications within a few years if untreated. Traditional management

Proactive Aflibercept Therapy in Severe NPDR: Insights from the PANORAMA Trial
3059 Reached2 Comments
Similar Content

Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes

Farmer with Pain, Redness, Watering and Reduced Vision in the Right Eye
2467 Reached5 Comments7 Likes

Corneal Endothelial Graft Rejection reversed after Dexamethasone Intravitreal Implant
2204 Reached6 Comments6 Likes

Secondary Pseudophakic Malignant Glaucoma
1621 Reached21 Comments12 Likes

Short-term Insulin Therapy for better Glycemic Control
14 Reached5 Comments6 Likes